Dimerization of a ubiquitin variant leads to high affinity interactions with a ubiquitin interacting motif.
dimer
phage display
protein engineering
ubiquitin
ubiquitin interacting motif
Journal
Protein science : a publication of the Protein Society
ISSN: 1469-896X
Titre abrégé: Protein Sci
Pays: United States
ID NLM: 9211750
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
03
01
2019
revised:
13
02
2019
accepted:
19
02
2019
pubmed:
23
2
2019
medline:
31
3
2020
entrez:
23
2
2019
Statut:
ppublish
Résumé
We previously described structural and functional characterization of the first ubiquitin variant (UbV), UbV.v27.1, engineered by phage display to bind with high affinity to a specific ubiquitin interacting motif (UIM). We identified two substitutions relative to ubiquitin (Gly10Val/His68Tyr) that were critical for enhancing binding affinity but could only rationalize the mechanism of action of the Tyr68 substitution. Here, we extend our characterization and uncover the mechanism by which the Val10 substitution enhances binding affinity. We show that Val10 in UbV.v27.1 drives UbV dimerization through an intermolecular β-strand exchange. Dimerization serves to increase the contact surface between the UIM and UbV and also affords direct contacts between two UIMs through an overall 2:2 binding stoichiometry. Our identification of the role of Val10 in UbV dimerization suggests a general means for the development of dimeric UbVs with improved affinity and specificity relative to their monomeric UbV counterparts. Statement: Previously, we used phage display to engineer a UbV that bound tightly and specifically to a UIM. Here, we discovered that tight binding is partly due to the dimerization of the UbV, which increases the contact surface between the UbV and UIM. We show that UbV dimerization is dependent on the Gly10Val substitution, and posit that dimerization may provide a general means for engineering UbVs with improved binding properties.
Identifiants
pubmed: 30793400
doi: 10.1002/pro.3593
pmc: PMC6459996
doi:
Substances chimiques
Ubiquitin
0
Valine
HG18B9YRS7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
848-856Subventions
Organisme : CIHR
ID : FDN143277
Pays : Canada
Organisme : CIHR
ID : MOP-136956
Pays : Canada
Informations de copyright
© 2019 The Protein Society.
Références
Acta Crystallogr D Biol Crystallogr. 2006 Apr;62(Pt 4):439-50
pubmed: 16552146
Mol Biosyst. 2006 Jan;2(1):49-57
pubmed: 16880922
EMBO J. 2003 Sep 15;22(18):4597-606
pubmed: 12970172
Biochemistry. 1991 Nov 12;30(45):10832-8
pubmed: 1932005
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Science. 2002 May 17;296(5571):1308-13
pubmed: 11964443
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Structure. 2019 Apr 2;27(4):590-605.e5
pubmed: 30713027
Protein Sci. 2017 May;26(5):1060-1069
pubmed: 28276594
Science. 2013 Feb 1;339(6119):590-5
pubmed: 23287719
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Mol Cell. 2017 Oct 19;68(2):456-470.e10
pubmed: 29053960
Structure. 1996 Sep 15;4(9):1077-92
pubmed: 8805593